Pfizer-BioNTech COVID-19 Bivalent Vaccine Booster Authorized for Use in Individuals Aged Six Months to Four Years, CR 116564
On March 28, 2023, we sent an announcement that we will cover the Pfizer-BioNTech bivalent COVID-19 vaccine booster for individuals ages six months to four years as outlined in the Emergency Use Authorization (EUA) form the